CSIMarket
 
Genocea Biosciences Inc   (GNCA)
Other Ticker:  
 
 

Genocea Biosciences Inc Growth Comparisons

Select each growth Category to receive further Information



GNCA Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) -68.38 % 36.94 % 19.74 % 14.5 %
Q / Q Revenue Growth (Q1 MRQ) -30.23 % -6.51 % 1.79 % -1.48 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 105.38 % 35.84 % 21.53 % %
Seq. Revenue Growth (for 12 months ending Q1 TTM) -2.68 % 7.45 % 2.79 % 3 %
Revenue 5 Year Average Growth 147.4 % 7.93 % 11.85 % 11.56 %


GNCA's Growth Comparisons in I. Quarter 2022




Genocea Biosciences Inc reported top-line of $ 0 millions in the first quarter 2022, compare to $ 1 millions in the same quarter a year ago. Revenues in the Biotechnology & Pharmaceuticals industry grew by 36.94%, while the top-line in the Healthcare sector increased by 19.74%, and overall market improved by 14.5% from the first quarter 2021.

Top-line fell by -30.23% from the forth quarter results. Comparing the annual growth, sales of 147.4% on average in last five years, to the S & P 500's, including only Businesses with the first quarter 2022 financial results, average yearly sales growth is 11.56%. Genocea Biosciences Inc grew faster than the market.


Growth Rates of GNCA's Income in the first quarter 2022


GNCA Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) - -32.45 % 14.32 % 14.73 %
Seq. Operating Income Change (Q1 MRQ) - -46.74 % 11.33 % -12.7 %
Y / Y Operating Income Growth (Q1 TTM) - 96.81 % 54.11 % 59.76 %
Seq. Operating Income Growth (Q1 TTM) - -3.78 % 0.4 % 2.49 %
Operating Income 5 Year Avg. Change - -9.62 % 10.14 % 16.38 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) - -70.11 % -3.08 % 12.59 %
Seq. Income from Cont. Ops. Change (Q1 MRQ) - -81.65 % 4.07 % 3.2 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) - 194.97 % 60.1 % 63.82 %
Seq. Income from Cont. Ops. Change (Q1 TTM) - -6.38 % -6.4 % 0.34 %
Income from Cont. Ops. 5 Year Avg. Change - 0.07 % 20.05 % 19.91 %

GNCA Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) - -70.11 % -3.47 % 13.8 %
Q / Q Net Income Growth (Q1 MRQ) - -80.5 % 5.18 % 3.68 %
Y / Y Net Income Change (Q1 TTM) - 190.77 % 63.33 % 67.8 %
Seq. Net Income Change (Q1 TTM) - -6.41 % -6.49 % 0.66 %
Net Income 5 Year Avg. Growth - -0.16 % 20.22 % 20.18 %

GNCA's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) - -82.1 % -3.08 % 12.59 %
Seq. EPS from Cont. Ops. Change (Q1 MRQ) - 142.42 % 4.07 % 3.2 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q1 TTM) - - - 6640.43 %
EPS from Cont. Ops. 5 Year Avg. Growth - -14.7 % 20.05 % 19.91 %



GNCA EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) - -82.1 % -3.47 % 19.91 %
Q / Q EPS Net Growth (Q1 MRQ) - 157.68 % 5.18 % 3.68 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - 40036.37 %
Seq. EPS Net Change (for 12 months ending Q1 TTM) - - - 55.38 %
EPS Net 5 Year Avg. Change - -0.16 % 20.22 % 20.18 %



Genocea Biosciences Inc reported bottom-line of $ -0.22 in the first quarter, compare to $ -0.17 in the same quarter a year ago. Biotechnology & Pharmaceuticals industry fell by -82.1%, while Healthcare sector decreased by -3.47%, and overall market improved by 13.8%.

Bottom-line fell by -30.23% from the forth quarter results. Comparing the annual growth, income per share of 147.4% on average in last five years, to the S & P 500's, including only Businesses with the first quarter 2022 earnings, average yearly income per share growth is 20.18%. Genocea Biosciences Inc grew faster than the market.

GNCA Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) - -59.59 % -3.47 % -0.56 %
Seq. Free Cash Flow Change (Q1 MRQ) - -64.12 % 13.16 % -42.06 %
Y / Y Free Cash Flow Change (Q1 TTM) - 13.18 % -9.46 % 35.72 %
Seq. Free Cash Flow Change (Q1 TTM) - -11.1 % -2.84 % -3.7 %
Free Cash Flow 5 Year Avg. Change - -0.52 % 20.48 % 25.45 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - - -
Seq. Net Cash Flow Change (Q1 MRQ) - - - -
Y / Y Net Cash Flow Change (Q1 TTM) - - - -85.17 %
Seq. Net Cash Flow Change (Q1 TTM) - - - -60.83 %
Net Cash Flow 5 Year Avg. Change - - 86 % 125.83 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) -13.35 % 34.01 % 2.13 % 11.66 %
Seq. Capital Expenditures Change (Q1 MRQ) 2.78 % -0.59 % -8.31 % -22.93 %
Y / Y Capital Expenditures Change (Q1 TTM) -9.27 % 37.83 % 10.76 % 20.71 %
Seq. Capital Expenditures Change (Q1 TTM) -4.5 % 7.24 % 1.59 % 2.76 %
Capital Expenditures 5 Year Avg. Change - 238.85 % 166.77 % 81.02 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com